12月以来,药明巨诺、恒瑞医药、南新制药等大批药企高管变动!

制药网
Dec 15

年末,国内医药行业高管变动进入密集期。根据梳理,近期,多家药企发布高管变动公告,涉及药明巨诺、恒瑞医药、南新制药、康恩贝等。其中,药明巨诺近日发布公告,称公司执行董事、董事局主席及行政总裁刘敏因个人事业发展原因已于2025年12月12日起辞职。同时,其宣布,任命田丰为公司行政总裁及执行董事,自2025年12月29日起生效。刘诚博士获委任为董事会主席,自2025年12月12日起生效。此外,药明巨诺的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10